Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by
Infinium Global Research on controlled substance market provides in-depth
analysis of segments and sub-segments in the global as well as regional
controlled substance market. The study also highlights the impact of drivers,
restraints, and macro indicators on the global and regional controlled
substance market over the short term as well as long term. The report is a
comprehensive presentation of trends, forecast and dollar values of the global
controlled substance market. According to the report, the global controlled
substance market is projected to grow at a CAGR of 14% over the forecast period
of 2019-2025.
Controlled substances are drug or
medication that causes physical and mental dependence. As it is illegal drugs
that can have a detrimental effect on a person's health and welfare, so federal
and state governments have regulated these substances. It includes opioids,
stimulants, depressants, hallucinogens, and anabolic steroids. Controlled
substances such as morphine, Valium, and Ritalin, are available only by
prescription from a licensed medical professional. Other controlled substances,
such as heroin and LSD, are illegal in the United States
The controlled substance molecule
is available in different dosages, which in turn, creates the demand for
controlled substances to treat diseases like ADHD that affects millions of
children across the world. Many pharmaceutical and biopharmaceutical company’s
investments in research and development to design therapeutics that are
delivered with benefits of these systems are propelling this market. In
addition, increasing government initiatives towards expenditure in R&D also
drives the market. Increasing demand for the controlled substances for the
management & treatment of a wide range of medical conditions, including
obesity, diarrhea suppression, and refractory exogenous obesity, which in turn
creates the productive demand of this market. However, the high cost associated
with the controlled substance drug yet remains one of the major restraints to
the market. On the other hand, in 2018, Epidiolex was approved by the FDA as a
first cannabis-derived drug that is used for the treatment of seizures. As it
contains a purified drug substance derived from marijuana, so it does not cause
intoxication or euphoria that comes from tetrahydrocannabinol (THC). Therefore,
increasing approval of drugs by the regulatory authorities such as Epidiolex
and its use in the many diseases such as Dravet syndrome offers favorable
opportunities in this market.
Geographically, the globally
controlled substance market is classified into North America, Asia-Pacific,
Europe, and the Rest of the World. Among all, North America holds the maximum
share in this market due to growing investments in R&D as well as awareness
about the controlled substance drug. On another hand, Europe holds the
second-largest share in this market owing to increasing research and
developmental activities as well as the presence of major pharmaceutical
companies in this region. Asia Pacific is expected to grow at the maximum CAGR
in the forecast period due to increasing development in the pharmaceutical
industry. In addition, the presence of a large geriatric population in Japan is
another factor boosting the market in these regions.
The report on global controlled
substance market covers segments such as technology, application, and end user.
On the basis of technology, the sub-markets include wurster technique,
coacervation, microencapsulation, implants, transdermal, targeted delivery, and
other technologies. On the basis of application, the sub-markets include
injectables, transdermal and ocular patches, infusion pumps, drug-eluting
stents, oral controlled-drug delivery systems, and metered dose inhalers. On
the basis of end user, the sub-markets include hospital pharmacies, online
pharmacies, retail pharmacies, research center, and other end users.
The report provides profiles of
the companies in the market such as Merck & Co., Inc., Alkermes plc,
Johnson & Johnson, Orbis Biosciences, Inc., Coating Place, Inc., Corium
International, Inc., Depomed, Inc., Pfizer, Inc, Aradigm Corporation, and
Capsugel.
The report provides deep insights
into the demand forecasts, market trends, and micro and macro indicators. In
addition, this report provides insights into the factors that are driving and
restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis
given in the report brings an insight into the investment areas that existing
or new market players can consider. The report provides insights into the
market using analytical tools such as Porter's five forces analysis and DRO
analysis of controlled substance market. Moreover, the study highlights current
market trends and provides forecast from 2019-2025. We also have highlighted
future trends in the market that will affect the demand during the forecast
period. Moreover, the competitive analysis given in each regional market brings
an insight into the market share of the leading players.
Please Choose One of them.